Blockchain Registration Transaction Record

MyBioSource Launches New Calretinin Antibody for Neuroscience Research

MyBioSource introduces new Sheep anti-Rat Calretinin antibody for neuroscience research, supporting studies in neurodegeneration and calcium signaling with cross-species reactivity.

This development matters because calretinin research is crucial for understanding neurodegenerative diseases like Alzheimer's and Parkinson's, as well as auditory disorders and calcium-related cellular mechanisms. The availability of high-quality, validated antibodies accelerates neuroscience research, potentially leading to breakthroughs in understanding brain function and developing treatments for neurological conditions. For researchers, this means access to a reliable tool that can cross-react with multiple species, saving time and resources while ensuring experimental consistency. The advancement supports the broader scientific community's efforts to unravel complex neurological pathways that affect millions worldwide.